byiShook Opinion
Aug 7, 2024 - 10:25
Novo Nordisk stock slumped Wednesday on its second-quarter earnings miss as sales of Wegovy and Ozempic both came in light. The post Novo Nordisk Slumps On Second-Quarter Miss, Light Ozempic, Wegovy Sales appeared first on Investor's Business Daily.
Novo Nordisk stock slumped Wednesday on its second-quarter earnings miss as sales of Wegovy and Ozempic both came in light.
The post Novo Nordisk Slumps On Second-Quarter Miss, Light Ozempic, Wegovy Sales appeared first on Investor's Business Daily.